Mindfulness-based therapy for inflammatory bowel disease patients with functional abdominal symptoms or high perceived stress levels

Journal of Crohn's and Colitis

Volumn 8, Issue 9, 2014, Pages 945-955

  Berrill, James W ^a   Sadlier, Mike ^b   Hood, Kerenza ^c   Green, John T ^a  

^a LLANDOUGH HOSPITAL   (United Kingdom)

^b UNIVERSITY HOSPITAL OF WALES   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Inflammatory bowel disease; Irritable bowel syndrome; Mindfulness; Psychotherapy

Indexed keywords

CALGRANULIN;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HOSPITAL ADMISSION; HUMAN; INFLAMMATORY BOWEL DISEASE; MALE; MINDFULNESS; MULTICONVERGENT THERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSYCHOTHERAPY; RECURRENCE RISK; REMISSION; STRESS; ABDOMINAL PAIN; ADOLESCENT; CLINICAL TRIAL; COMPLICATION; INFLAMMATORY BOWEL DISEASES; MENTAL STRESS; MIDDLE AGED; MULTICENTER STUDY; PROCEDURES; PSYCHOLOGY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RETROSPECTIVE STUDY; TREATMENT OUTCOME; YOUNG ADULT; ABDOMINAL DISCOMFORT; BIG FIVE INVENTORY; CHECKLIST; COPING BEHAVIOR; CROHN DISEASE; DISEASE ACTIVITY; INFLAMMATORY BOWEL DISEASE QUESTIONNAIRE; INTERPERSONAL SUPPORT EVALUATION LIST; IRRITABLE BOWEL SYNDROME SYMPTOM SEVERITY SCALE; MAJOR CLINICAL STUDY; NATIONAL ADULT READING TEST; PERCEIVED STRESS SCALE; RATING SCALE; ULCERATIVE COLITIS; WAYS OF COPING QUESTIONNAIRE;

ABDOMINAL PAIN; ADOLESCENT; ADULT; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MIDDLE AGED; MINDFULNESS; QUESTIONNAIRES; RETROSPECTIVE STUDIES; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84906790095     PISSN: 18739946     EISSN: 18764479     Source Type: Journal    
DOI: 10.1016/j.crohns.2014.01.018     Document Type: Article

References (50)

1. Boye B., Lundin K.E., Jantschek G., Leganger S., Mokleby K., Tangen T., et al. INSPIRE Study: does stress management improve the course of inflammatory bowel disease and disease-specific quality of life in distressed patients with ulcerative colitis or Crohn's disease? A randomized controlled trial. Inflamm Bowel Dis Sep 2011, 17(9):1863-1873.
2. Deter H.C., Keller W., von Wietersheim J., Jantschek G., Duchmann R., Zeitz M. Psychological treatment may reduce the need for healthcare in patients with Crohn's disease. Inflamm Bowel Dis Jun 2007, 13(6):745-752.
3. Garcia-Vega E., Fernandez-Rodriguez C. A stress management programme for Crohn's disease. Behav Res Ther Apr 2004, 42(4):367-383.
4. Keefer L., Keshavarzian A. Feasibility and acceptability of gut-directed hypnosis on inflammatory bowel disease: a brief communication. Int J Clin Exp Hypn Oct 2007, 55(4):457-466.
5. Goodhand J.R., Wahed M., Rampton D.S. Management of stress in inflammatory bowel disease: a therapeutic option?. Expert Rev Gastroenterol Hepatol Dec 2009, 3(6):661-679.
6. von Wietersheim J., Kessler H. Psychotherapy with chronic inflammatory bowel disease patients: a review. Inflamm Bowel Dis Dec 2006, 12(12):1175-1184.
7. McCombie A.M., Mulder R.T., Gearry R.B. Psychotherapy for inflammatory bowel disease: a review and update. J Crohns Colitis 2013 Dec 15, 7(12):935-949.
8. Knowles S.R., Monshat K., Castle D.J. The efficacy and methodological challenges of psychotherapy for adults with inflammatory bowel disease: a review. Inflamm Bowel Dis 2013 Nov, 19(12):2704-2715.
9. Timmer A., Preiss J.C., Motschall E., Rucker G., Jantschek G., Moser G. Psychological interventions for treatment of inflammatory bowel disease. Cochrane Database Syst Rev 2011, 2. CD006913.
10. Halpin S.J., Ford A.C. Prevalence of symptoms meeting criteria for irritable bowel syndrome in inflammatory bowel disease: systematic review and meta-analysis. Am J Gastroenterol Oct 2012, 107(10):1474-1482.
11. Berrill J.W., Green J.T., Hood K., Campbell A.K. Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. Aliment Pharmacol Ther Jul 2013, 38(1):44-51.
12. Farrokhyar F., Marshall J.K., Easterbrook B., Irvine E.J. Functional gastrointestinal disorders and mood disorders in patients with inactive inflammatory bowel disease: prevalence and impact on health. Inflamm Bowel Dis Jan 2006, 12(1):38-46.
13. Simren M., Axelsson J., Gillberg R., Abrahamsson H., Svedlund J., Bjornsson E.S. Quality of life in inflammatory bowel disease in remission: the impact of IBS-like symptoms and associated psychological factors. Am J Gastroenterol Feb 2002, 97(2):389-396.
14. Ford A.C., Talley N.J., Schoenfeld P.S., Quigley E.M., Moayyedi P. Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut Mar 2009, 58(3):367-378.
15. Webb A.N., Kukuruzovic R.H., Catto-Smith A.G., Sawyer S.M. Hypnotherapy for treatment of irritable bowel syndrome. Cochrane Database Syst Rev 2007, 4. CD005110.
16. NICE Irritable bowel syndrome in adults: diagnosis and management of irritable bowel syndrome in primary care 2008.
17. Spiller R., Aziz Q., Creed F., Emmanuel A., Houghton L., Hungin P., et al. Guidelines on the irritable bowel syndrome: mechanisms and practical management. Gut Dec 2007, 56(12):1770-1798.
18. Bernstein C.N., Singh S., Graff L.A., Walker J.R., Miller N., Cheang M. A prospective population-based study of triggers of symptomatic flares in IBD. Am J Gastroenterol Sep 2010, 105(9):1994-2002.
19. Levenstein S., Prantera C., Varvo V., Scribano M.L., Andreoli A., Luzi C., et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol May 2000, 95(5):1213-1220.
20. Mittermaier C., Dejaco C., Waldhoer T., Oefferlbauer-Ernst A., Miehsler W., Beier M., et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med Jan-Feb 2004, 66(1):79-84.
21. Lahiff C., Safaie P., Awais A., Akbari M., Gashin L., Sheth S., et al. The Crohn's Disease Activity Index (CDAI) is similarly elevated in patients with Crohn's disease and in patients with irritable bowel syndrome. Aliment Pharmacol Ther Apr 2013, 37(8):786-794.
22. Baer R.A. Mindfulness training as a clinical intervention: a conceptual and empirical review. Clin Psychol Sci Pract 2003, 10:125-143.
23. Shaw G., Srivastava E.D., Sadlier M., Swann P., James J.Y., Rhodes J. Stress management for irritable bowel syndrome: a controlled trial. Digestion 1991, 50(1):36-42.
24. Sadlier M., Stephens S.D., Kennedy V. Tinnitus rehabilitation: a mindfulness meditation cognitive behavioural therapy approach. J Laryngol Otol Jan 2008, 122(1):31-37.
25. Thomas M., Sadlier M., Smith A. The effect of multi convergent therapy on the psychopathology, mood and performance of chronic fatigue syndrome patients: a preliminary study. Couns Psychother Res 2006, 6(2):91-99.
26. Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohns Colitis Mar 2008, 2(1):1-23.
27. Van Assche G., Dignass A., Panes J., Beaugerie L., Karagiannis J., Allez M., et al. The second European evidence-based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. J Crohns Colitis Feb 2010, 4(1):7-27.
28. Silverberg M.S., Satsangi J., Ahmad T., Arnott I.D., Bernstein C.N., Brant S.R., et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol Sep 2005, 19(Suppl. A):5-36.
29. Longstreth G.F., Thompson W.G., Chey W.D., Houghton L.A., Mearin F., Spiller R.C. Functional bowel disorders. Gastroenterology Apr 2006, 130(5):1480-1491.
30. Francis C.Y., Morris J., Whorwell P.J. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther Apr 1997, 11(2):395-402.
31. DeLongis A., Folkman S., Lazarus R.S. The impact of daily stress on health and mood: psychological and social resources as mediators. J Pers Soc Psychol Mar 1988, 54(3):486-495.
32. Levenstein S., Prantera C., Varvo V., Scribano M.L., Berto E., Luzi C., et al. Development of the Perceived Stress Questionnaire: a new tool for psychosomatic research. J Psychosom Res Jan 1993, 37(1):19-32.
33. Vitaliano P.P., Russo J., Carr J.E., Maiuro R.D., Becker J. The Ways of Coping Checklist: revision and psychometric properties. Multivar Behav Res 1985, 20:3-26.
34. Guyatt G., Mitchell A., Irvine E.J., Singer J., Williams N., Goodacre R., et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology Mar 1989, 96(3):804-810.
35. Nelson H.E. National Adult Reading Test (NART): test manual: Windsor: NFER-Nelson 1982.
36. John O.P., Robins R.W., Pervin L.A. Handbook of personality: theory and research 2008, Guildford Press, New York.
37. Cohen S., Hoberman H. Positive events and social supports as buffers of life change stress. J Appl Soc Psychol 1983, 13:99-124.
38. Zigmoid A.S., Snaith R.P. The Hospital Anxiety and Depression Scale. Acta Psychiatr Scand 1983, 67:361-370.
39. Walmsley R.S., Ayres R.C., Pounder R.E., Allan R.N. A Simple Clinical Colitis Activity Index. Gut Jul 1998, 43(1):29-32.
40. Harvey R.F., Bradshaw J.M. A simple index of Crohn's-disease activity. Lancet Mar 8 1980, 1(8167):514.
41. Vidal A., Gomez-Gil E., Sans M., Portella M.J., Salamero M., Pique J.M., et al. Health-related quality of life in inflammatory bowel disease patients: the role of psychopathology and personality. Inflamm Bowel Dis Jul 2008, 14(7):977-983.
42. D'Haens G., Sandborn W.J., Feagan B.G., Geboes K., Hanauer S.B., Irvine E.J., et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology Feb 2007, 132(2):763-786.
43. Landis J.R., Koch G.G. The measurement of observer agreement for categorical data. Biometrics Mar 1977, 33(1):159-174.
44. Spiller R.C. Problems and challenges in the design of irritable bowel syndrome clinical trials: experience from published trials. Am J Med Nov 8 1999, 107(5A):91S-97S.
45. Patel S.M., Stason W.B., Legedza A., Ock S.M., Kaptchuk T.J., Conboy L., et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil Jun 2005, 17(3):332-340.
46. Ljotsson B., Falk L., Vesterlund A.W., Hedman E., Lindfors P., Ruck C., et al. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome-a randomized controlled trial. Behav Res Ther Jun 2010, 48(6):531-539.
47. Kearney D.J., McDermott K., Martinez M., Simpson T.L. Association of participation in a mindfulness programme with bowel symptoms, gastrointestinal symptom-specific anxiety and quality of life. Aliment Pharmacol Ther Aug 2011, 34(3):363-373.
48. Gaylord S.A., Palsson O.S., Garland E.L., Faurot K.R., Coble R.S., Mann J.D., et al. Mindfulness training reduces the severity of irritable bowel syndrome in women: results of a randomized controlled trial. Am J Gastroenterol Sep 2011, 106(9):1678-1688.
49. Miehsler W., Weichselberger M., Offerlbauer-Ernst A., Dejaco C., Reinisch W., Vogelsang H., et al. Which patients with IBD need psychological interventions?. A controlled study, Inflamm Bowel Dis Sep 2008, 14(9):1273-1280.
50. Gearry R.B., Irving P.M., Barrett J.S., Nathan D.M., Shepherd S.J., Gibson P.R. Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease--a pilot study. J Crohns Colitis Feb 2009, 3(1):8-14.